Your browser doesn't support javascript.
loading
Accurate classification of secondary progression in multiple sclerosis using a decision tree.
Ramanujam, Ryan; Zhu, Feng; Fink, Katharina; Karrenbauer, Virginija Danylaite; Lorscheider, Johannes; Benkert, Pascal; Kingwell, Elaine; Tremlett, Helen; Hillert, Jan; Manouchehrinia, Ali.
Affiliation
  • Ramanujam R; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden/Department of Mathematics, KTH-Royal Institute of Technology, Stockholm, Sweden.
  • Zhu F; Faculty of Medicine (Neurology), UBC Hospital, and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.
  • Fink K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden/Neuro Theme, Karolinska University Hospital, Stockholm, Sweden/Academic Specialist Center, Multiple Sclerosis Centre, Stockholm, Sweden.
  • Karrenbauer VD; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden/Neuro Theme, Karolinska University Hospital, Stockholm, Sweden.
  • Lorscheider J; Neurologic Clinic and Policlinic, Departments of Medicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Benkert P; Clinical Trial Unit, Department of Clinical Research, University Hospital Basel, Basel, Switzerland.
  • Kingwell E; Faculty of Medicine (Neurology), UBC Hospital, and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.
  • Tremlett H; Faculty of Medicine (Neurology), UBC Hospital, and Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.
  • Hillert J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden/Neuro Theme, Karolinska University Hospital, Stockholm, Sweden.
  • Manouchehrinia A; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden/The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centre for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden.
Mult Scler ; 27(8): 1240-1249, 2021 07.
Article in En | MEDLINE | ID: mdl-33263261

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis Type of study: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Sweden Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis Type of study: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Sweden Country of publication: United kingdom